Movatterモバイル変換


[0]ホーム

URL:


Skip to main content
                                  NCBI home page
Search in PMCSearch
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more:PMC Disclaimer | PMC Copyright Notice
Canadian Medical Association Journal logo
. 1973 Jan 6;108(1):33–38.

Problems in selection of topical anti-inflammatory corticosteroids

Wm D Stewart,J O Runikis,S C Verma,S Wallace
PMCID: PMC1941108  PMID:4682636

Abstract

Desonide, a non-fluorinated topical corticosteroid (16-alpha-hydroxyprednisolone acetonide), is compared with its fluorinated analogue, triamcinolone acetonide, as to vasoconstriction ability and epidermal penetration rate. Clinical effectiveness of desonide is further assessed by means of a double-blind paired comparison with an accepted potent fluorinated steroid, betamethasone 17-valerate. It is demonstrated that fluorination of the steroid molecule is not necessary to achieve potent topical anti-inflammatory effect. Vasoconstriction and epidermal penetration are not enhanced by fluorination in the drugs studied.

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bluefarb S. M. Clinical comparison of desonide cream with betamethasone valerate cream. A double-blind randomized study. Int J Dermatol. 1972 Apr-Jun;11(2):73–76. doi: 10.1111/j.1365-4362.1972.tb01727.x. [DOI] [PubMed] [Google Scholar]
  2. Coldman M. F., Poulsen B. J., Higuchi T. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J Pharm Sci. 1969 Sep;58(9):1098–1102. doi: 10.1002/jps.2600580912. [DOI] [PubMed] [Google Scholar]
  3. MCKENZIE A. W., ATKINSON R. M. TOPICAL ACTIVITIES OF BETAMETHASONE ESTERS IN MAN. Arch Dermatol. 1964 May;89:741–746. doi: 10.1001/archderm.1964.01590290107016. [DOI] [PubMed] [Google Scholar]
  4. Macdonald A. Topical corticosteroid preparations. Hazards and side-effects. Br J Clin Pract. 1971 Sep;25(9):421–425. [PubMed] [Google Scholar]
  5. Mantica L., Ciceri R., Assagne J. P., Mascitelli-Coriandoli E. Prednacinolone, a new anti-inflammatory steroid. 1. Chemical and physical properties. Arzneimittelforschung. 1970 Jan;20(1):109–110. [PubMed] [Google Scholar]
  6. Nunis J. B., Noojin R. O. A comparative study of topical corticosteroids. South Med J. 1969 Jan;62(1):30–32. doi: 10.1097/00007611-196901000-00007. [DOI] [PubMed] [Google Scholar]
  7. Ostrenga J., Steinmetz C., Poulsen B. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. J Pharm Sci. 1971 Aug;60(8):1175–1179. doi: 10.1002/jps.2600600812. [DOI] [PubMed] [Google Scholar]
  8. Ostrenga J., Steinmetz C., Poulsen B., Yett S. Significance of vehicle composition. II. Prediction of optimal vehicle composition. J Pharm Sci. 1971 Aug;60(8):1180–1183. doi: 10.1002/jps.2600600813. [DOI] [PubMed] [Google Scholar]
  9. Phillips B. M., Sanen F. J., Leeling J. L., Hammes T. L., Hartnagel R. E., Sancilio L. F., Lorenzetti O. J., Kraus P. J. The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid. Toxicol Appl Pharmacol. 1971 Dec;20(4):522–537. doi: 10.1016/0041-008x(71)90256-0. [DOI] [PubMed] [Google Scholar]
  10. Place V. A., Velazquez J. G., Burdick K. H. Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay. Arch Dermatol. 1970 May;101(5):531–537. [PubMed] [Google Scholar]
  11. Reid J., Brookes D. B. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity. Br J Dermatol. 1968 May;80(5):328–336. doi: 10.1111/j.1365-2133.1968.tb12307.x. [DOI] [PubMed] [Google Scholar]
  12. SARETT L. H., PATCHETT A. A., STEELMAN S. L. THE EFFECTS OF STRUCTURAL ALTERATION ON THE ANTI-INFLAMMATORY PROPERTIES OF HYDROCORTISONE. Fortschr Arzneimittelforsch. 1963;5:11–153. doi: 10.1007/978-3-0348-7047-4_1. [DOI] [PubMed] [Google Scholar]
  13. SCHLAGEL C. A. COMPARATIVE EFFICACY OF TOPICAL ANTI-INFLAMMATORY CORTICOSTEROIDS. J Pharm Sci. 1965 Mar;54:335–354. doi: 10.1002/jps.2600540302. [DOI] [PubMed] [Google Scholar]
  14. Scheuplein R. J., Blank I. H., Brauner G. J., MacFarlane D. J. Percutaneous absorption of steroids. J Invest Dermatol. 1969 Jan;52(1):63–70. doi: 10.1038/jid.1969.9. [DOI] [PubMed] [Google Scholar]
  15. Scheuplein R. J. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967 Jan;48(1):79–88. [PubMed] [Google Scholar]
  16. Stoughton R. B. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison. Arch Dermatol. 1969 Jun;99(6):753–756. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy ofCanadian Medical Association

ACTIONS

RESOURCES


[8]ページ先頭

©2009-2025 Movatter.jp